HEADER TRANSFERASE 29-SEP-08 3EOS TITLE TRNA-GUANINE TRANSGLYCOSYLASE IN COMPLEX WITH 6-AMINO-4-{2- TITLE 2 [(CYCLOHEXYLMETHYL)AMINO]ETHYL}-2-(METHYLAMINO)-1,7-DIHYDRO-8H- TITLE 3 IMIDAZO[4,5-G]QUINAZOLIN-8-ONE COMPND MOL_ID: 1; COMPND 2 MOLECULE: QUEUINE TRNA-RIBOSYLTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: TGT, TRNA-GUANINE TRANSGLYCOSYLASE, GUANINE INSERTION COMPND 5 ENZYME; COMPND 6 EC: 2.4.2.29; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ZYMOMONAS MOBILIS; SOURCE 3 ORGANISM_TAXID: 542; SOURCE 4 GENE: TGT; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET9D KEYWDS TIM BARREL, GLYCOSYLTRANSFERASE, METAL-BINDING, QUEUOSINE KEYWDS 2 BIOSYNTHESIS, TRANSFERASE, TRNA PROCESSING EXPDTA X-RAY DIFFRACTION AUTHOR T.RITSCHEL,A.HEINE,G.KLEBE REVDAT 4 01-NOV-23 3EOS 1 REMARK REVDAT 3 13-JUL-11 3EOS 1 VERSN REVDAT 2 08-DEC-09 3EOS 1 JRNL REVDAT 1 15-SEP-09 3EOS 0 JRNL AUTH T.RITSCHEL,P.C.KOHLER,G.NEUDERT,A.HEINE,F.DIEDERICH,G.KLEBE JRNL TITL HOW TO REPLACE THE RESIDUAL SOLVATION SHELL OF POLAR ACTIVE JRNL TITL 2 SITE RESIDUES TO ACHIEVE NANOMOLAR INHIBITION OF JRNL TITL 3 TRNA-GUANINE TRANSGLYCOSYLASE JRNL REF CHEMMEDCHEM V. 4 2012 2009 JRNL REFN ISSN 1860-7179 JRNL PMID 19894214 JRNL DOI 10.1002/CMDC.200900343 REMARK 2 REMARK 2 RESOLUTION. 1.78 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.78 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 94.1 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.175 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.173 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1837 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 36550 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.159 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.157 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.213 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1434 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 28454 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2718 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 244 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 3003.5 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2663.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 5 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 12144 REMARK 3 NUMBER OF RESTRAINTS : 11522 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 ANGLE DISTANCES (A) : 0.024 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.024 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.040 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.045 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.016 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.000 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.041 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH AND HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC SCALING APPLIED BY THE REMARK 3 METHOD OF PARKIN, MOEZZI & HOPE, J.APPL.CRYST.28(1995)53-56 REMARK 4 REMARK 4 3EOS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-OCT-08. REMARK 100 THE DEPOSITION ID IS D_1000049587. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-APR-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : YALE MIRROR REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 38665 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.780 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06000 REMARK 200 FOR THE DATA SET : 15.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.78 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.9 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.39000 REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: AB INITIO REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1P0E REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100MM TRIS HCL, 1MM DTT, 10% DMSO, 5% REMARK 280 PEG 8000, PH 5.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 288K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 45.60000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.40000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 45.60000 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 32.40000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 24840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1142 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 VAL A 2 REMARK 465 GLU A 3 REMARK 465 ALA A 4 REMARK 465 THR A 5 REMARK 465 ALA A 6 REMARK 465 GLN A 7 REMARK 465 GLU A 8 REMARK 465 THR A 9 REMARK 465 ASP A 10 REMARK 465 SER A 112 REMARK 465 SER A 113 REMARK 465 LEU A 114 REMARK 465 THR A 115 REMARK 465 LYS A 125 REMARK 465 SER A 126 REMARK 465 HIS A 127 REMARK 465 LEU A 128 REMARK 465 ASP A 129 REMARK 465 GLY A 130 REMARK 465 SER A 131 REMARK 465 ARG A 132 REMARK 465 THR A 285 REMARK 465 ARG A 286 REMARK 465 SER A 287 REMARK 465 GLY A 288 REMARK 465 ARG A 289 REMARK 465 ARG A 384 REMARK 465 ASN A 385 REMARK 465 SER A 386 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 57 CG CD OE1 OE2 REMARK 470 ARG A 77 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 111 CG CD1 CD2 REMARK 470 LYS A 116 CG CD CE NZ REMARK 470 GLU A 120 CG CD OE1 OE2 REMARK 470 MET A 134 CG SD CE REMARK 470 ARG A 167 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 190 CG CD CE NZ REMARK 470 GLU A 191 CG CD OE1 OE2 REMARK 470 GLU A 220 CG CD OE1 OE2 REMARK 470 LYS A 264 CG CD CE NZ REMARK 470 LEU A 283 CG CD1 CD2 REMARK 470 ASN A 290 CG OD1 ND2 REMARK 470 GLN A 324 CG CD OE1 NE2 REMARK 470 SER A 371 OG REMARK 470 GLN A 375 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 34 NE - CZ - NH2 ANGL. DEV. = -3.0 DEGREES REMARK 500 GLN A 203 C - N - CA ANGL. DEV. = 15.8 DEGREES REMARK 500 ASP A 266 CB - CG - OD2 ANGL. DEV. = 7.0 DEGREES REMARK 500 ARG A 378 NE - CZ - NH2 ANGL. DEV. = -3.9 DEGREES REMARK 500 ARG A 380 CD - NE - CZ ANGL. DEV. = 11.6 DEGREES REMARK 500 ARG A 380 NE - CZ - NH1 ANGL. DEV. = 4.6 DEGREES REMARK 500 ARG A 380 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 47 -60.22 -93.74 REMARK 500 ALA A 48 71.04 -153.71 REMARK 500 ASN A 70 76.61 -110.70 REMARK 500 SER A 205 -129.48 47.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 387 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 318 SG REMARK 620 2 CYS A 320 SG 106.2 REMARK 620 3 CYS A 323 SG 113.8 118.7 REMARK 620 4 HIS A 349 ND1 106.1 111.6 100.0 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 387 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PK2 A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3EOU RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH ANOTHER INHIBITOR REMARK 900 RELATED ID: 3C2N RELATED DB: PDB REMARK 900 THE SAME PROTEIN IN COMPLEX WITH ANOTHER INHIBITOR REMARK 999 REMARK 999 SEQUENCE REMARK 999 312TH RESIDUE IS LYS ACCORDING TO REUTER K.K.H. ET AL [J. REMARK 999 BACTERIOL. 177:5284-5288(1995)] AND AHN J.Y. ET AL REMARK 999 [SUBMITTED (OCT-2000) TO THE EMBL/GENBANK/DDBJ DATABASES] DBREF 3EOS A 1 386 UNP P28720 TGT_ZYMMO 1 386 SEQADV 3EOS LYS A 312 UNP P28720 THR 312 SEE REMARK 999 SEQRES 1 A 386 MET VAL GLU ALA THR ALA GLN GLU THR ASP ARG PRO ARG SEQRES 2 A 386 PHE SER PHE SER ILE ALA ALA ARG GLU GLY LYS ALA ARG SEQRES 3 A 386 THR GLY THR ILE GLU MET LYS ARG GLY VAL ILE ARG THR SEQRES 4 A 386 PRO ALA PHE MET PRO VAL GLY THR ALA ALA THR VAL LYS SEQRES 5 A 386 ALA LEU LYS PRO GLU THR VAL ARG ALA THR GLY ALA ASP SEQRES 6 A 386 ILE ILE LEU GLY ASN THR TYR HIS LEU MET LEU ARG PRO SEQRES 7 A 386 GLY ALA GLU ARG ILE ALA LYS LEU GLY GLY LEU HIS SER SEQRES 8 A 386 PHE MET GLY TRP ASP ARG PRO ILE LEU THR ASP SER GLY SEQRES 9 A 386 GLY TYR GLN VAL MET SER LEU SER SER LEU THR LYS GLN SEQRES 10 A 386 SER GLU GLU GLY VAL THR PHE LYS SER HIS LEU ASP GLY SEQRES 11 A 386 SER ARG HIS MET LEU SER PRO GLU ARG SER ILE GLU ILE SEQRES 12 A 386 GLN HIS LEU LEU GLY SER ASP ILE VAL MET ALA PHE ASP SEQRES 13 A 386 GLU CYS THR PRO TYR PRO ALA THR PRO SER ARG ALA ALA SEQRES 14 A 386 SER SER MET GLU ARG SER MET ARG TRP ALA LYS ARG SER SEQRES 15 A 386 ARG ASP ALA PHE ASP SER ARG LYS GLU GLN ALA GLU ASN SEQRES 16 A 386 ALA ALA LEU PHE GLY ILE GLN GLN GLY SER VAL PHE GLU SEQRES 17 A 386 ASN LEU ARG GLN GLN SER ALA ASP ALA LEU ALA GLU ILE SEQRES 18 A 386 GLY PHE ASP GLY TYR ALA VAL GLY GLY LEU ALA VAL GLY SEQRES 19 A 386 GLU GLY GLN ASP GLU MET PHE ARG VAL LEU ASP PHE SER SEQRES 20 A 386 VAL PRO MET LEU PRO ASP ASP LYS PRO HIS TYR LEU MET SEQRES 21 A 386 GLY VAL GLY LYS PRO ASP ASP ILE VAL GLY ALA VAL GLU SEQRES 22 A 386 ARG GLY ILE ASP MET PHE ASP CYS VAL LEU PRO THR ARG SEQRES 23 A 386 SER GLY ARG ASN GLY GLN ALA PHE THR TRP ASP GLY PRO SEQRES 24 A 386 ILE ASN ILE ARG ASN ALA ARG PHE SER GLU ASP LEU LYS SEQRES 25 A 386 PRO LEU ASP SER GLU CYS HIS CYS ALA VAL CYS GLN LYS SEQRES 26 A 386 TRP SER ARG ALA TYR ILE HIS HIS LEU ILE ARG ALA GLY SEQRES 27 A 386 GLU ILE LEU GLY ALA MET LEU MET THR GLU HIS ASN ILE SEQRES 28 A 386 ALA PHE TYR GLN GLN LEU MET GLN LYS ILE ARG ASP SER SEQRES 29 A 386 ILE SER GLU GLY ARG PHE SER GLN PHE ALA GLN ASP PHE SEQRES 30 A 386 ARG ALA ARG TYR PHE ALA ARG ASN SER HET ZN A 387 1 HET PK2 A 400 27 HET GOL A 600 6 HET GOL A 601 6 HETNAM ZN ZINC ION HETNAM PK2 6-AMINO-4-{2-[(CYCLOHEXYLMETHYL)AMINO]ETHYL}-2- HETNAM 2 PK2 (METHYLAMINO)-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN- HETNAM 3 PK2 8-ONE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 ZN ZN 2+ FORMUL 3 PK2 C19 H27 N7 O FORMUL 4 GOL 2(C3 H8 O3) FORMUL 6 HOH *244(H2 O) HELIX 1 1 LYS A 55 THR A 62 1 8 HELIX 2 2 ASN A 70 ARG A 77 1 8 HELIX 3 3 GLY A 79 LEU A 86 1 8 HELIX 4 4 GLY A 88 GLY A 94 1 7 HELIX 5 5 GLY A 104 LEU A 111 1 8 HELIX 6 6 SER A 136 GLY A 148 1 13 HELIX 7 7 THR A 164 SER A 188 1 25 HELIX 8 8 ARG A 189 ALA A 196 1 8 HELIX 9 9 PHE A 207 GLY A 222 1 16 HELIX 10 10 GLY A 236 VAL A 248 1 13 HELIX 11 11 PRO A 249 LEU A 251 5 3 HELIX 12 12 LYS A 264 ARG A 274 1 11 HELIX 13 13 ASN A 304 SER A 308 5 5 HELIX 14 14 CYS A 320 TRP A 326 1 7 HELIX 15 15 SER A 327 ALA A 337 1 11 HELIX 16 16 GLU A 339 GLU A 367 1 29 HELIX 17 17 ARG A 369 PHE A 382 1 14 SHEET 1 A 3 SER A 15 GLU A 22 0 SHEET 2 A 3 ALA A 25 MET A 32 -1 O THR A 29 N SER A 17 SHEET 3 A 3 GLY A 35 THR A 39 -1 O ILE A 37 N ILE A 30 SHEET 1 B 8 ALA A 41 PRO A 44 0 SHEET 2 B 8 MET A 278 CYS A 281 1 O PHE A 279 N MET A 43 SHEET 3 B 8 HIS A 257 LEU A 259 1 N LEU A 259 O MET A 278 SHEET 4 B 8 GLY A 225 VAL A 228 1 N VAL A 228 O TYR A 258 SHEET 5 B 8 ALA A 197 GLN A 202 1 N GLY A 200 O ALA A 227 SHEET 6 B 8 ILE A 151 MET A 153 1 N VAL A 152 O ALA A 197 SHEET 7 B 8 ILE A 99 THR A 101 1 N THR A 101 O ILE A 151 SHEET 8 B 8 ILE A 67 GLY A 69 1 N GLY A 69 O LEU A 100 SHEET 1 C 2 GLN A 117 SER A 118 0 SHEET 2 C 2 GLY A 121 VAL A 122 -1 O GLY A 121 N SER A 118 SHEET 1 D 2 GLN A 292 ALA A 293 0 SHEET 2 D 2 ILE A 300 ASN A 301 -1 O ILE A 300 N ALA A 293 LINK SG CYS A 318 ZN ZN A 387 1555 1555 2.28 LINK SG CYS A 320 ZN ZN A 387 1555 1555 2.27 LINK SG CYS A 323 ZN ZN A 387 1555 1555 2.34 LINK ND1 HIS A 349 ZN ZN A 387 1555 1555 2.24 CISPEP 1 THR A 39 PRO A 40 0 -3.28 CISPEP 2 ARG A 77 PRO A 78 0 9.14 CISPEP 3 TYR A 161 PRO A 162 0 1.69 CISPEP 4 VAL A 262 GLY A 263 0 -3.71 SITE 1 AC1 4 CYS A 318 CYS A 320 CYS A 323 HIS A 349 SITE 1 AC2 18 VAL A 45 ASN A 70 ASP A 102 SER A 103 SITE 2 AC2 18 TYR A 106 GLN A 107 ASP A 156 CYS A 158 SITE 3 AC2 18 GLN A 203 GLY A 229 GLY A 230 LEU A 231 SITE 4 AC2 18 ALA A 232 MET A 260 GLY A 261 ASP A 280 SITE 5 AC2 18 VAL A 282 HOH A1027 SITE 1 AC3 7 PRO A 56 GLU A 57 GLY A 94 TRP A 95 SITE 2 AC3 7 ASP A 96 ARG A 97 HOH A1158 SITE 1 AC4 6 GLU A 317 LYS A 360 PHE A 373 ARG A 380 SITE 2 AC4 6 HOH A1015 HOH A1195 CRYST1 91.200 64.800 70.100 90.00 95.90 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010965 0.000000 0.001133 0.00000 SCALE2 0.000000 0.015432 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014341 0.00000